Trials / Completed
CompletedNCT05075941
Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations
PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,811 (actual)
- Sponsor
- Epicentre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The main objective of the study is to assess the level of vaccination coverage (VC) against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing. The secondary objectives are : * to compare the estimated level of vaccination coverage in the different sites and strata (emergency shelters/hotels, camps, workers' hostels, on the street) with the estimated level in the general population of the same territory obtained from the French Health Insurance data (SIVAC). * identify the obstacles and leverage of vaccination (i.e. mobile team) according to living conditions and habitat (socio-demographic factors, personal health history, vaccine adherence, local health policies, etc.).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Vaccination coverage | proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population |
Timeline
- Start date
- 2021-11-15
- Primary completion
- 2021-12-22
- Completion
- 2021-12-22
- First posted
- 2021-10-13
- Last updated
- 2023-04-06
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05075941. Inclusion in this directory is not an endorsement.